SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-04-012719
Filing Date
2004-06-14
Accepted
2004-06-14 11:09:48
Documents
2
Period of Report
2004-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2642
2 POWER OF ATTORNEY ex24tkeilani.txt EX-24 2894
  Complete submission text file 0001179110-04-012719.txt   7468
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Issuer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 145 WATERMAN ROAD CANTON MA 02021
Business Address 781-433-3116
Keilani Taha (Reporting) CIK: 0001293434 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-15006 | Film No.: 04860196